{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:46:07Z","timestamp":1782794767354,"version":"3.54.5"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hypertrophic osteoarthropathy (PHO) is a rare hereditary clinical syndrome characterized by digital clubbing, periostosis, and pachydermia. It is mainly caused by mutations in SLCO2A1 or HPGD, leading to impaired degradation and elevated levels of prostaglandin E2 (PGE2). In addition to the typical skeletal and skin manifestations, some patients may present with gastrointestinal or hematologic abnormalities, including anemia and myelofibrosis. This report describes a case of PHO with myelofibrosis and compound heterozygous SLCO2A1 mutations and review the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>A 45-year-old man presented with a long history of severe fatigue and recurrent anemia accompanied by digital clubbing and skin thickening. Bone marrow biopsy revealed myelofibrosis, and imaging studies showed periostosis of the long bones. Given the anemia and gastrointestinal symptoms, differential diagnoses included Crohn\u2019s disease, intestinal tuberculosis, and other hematologic disorders associated with myelofibrosis, which were excluded by endoscopic and hematologic evaluations. Whole-exome sequencing revealed that the patient carried compound heterozygous variants in SLCO2A1 (c.940\u00a0+\u00a01G&amp;gt;A and c.440G&amp;gt;A\/p.Trp147*), confirming the diagnosis of PHO. Family investigation showed that his parents and offspring were all asymptomatic carriers with one heterozygous variant, which is consistent with autosomal recessive inheritance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Myelofibrosis is a rare but important complication of PHO and may be more frequent in patients with biallelic SLCO2A1 variants. Genetic testing and hematologic evaluation in PHO patients can help with early identification of related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1772374","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:28Z","timestamp":1782793468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary hypertrophic osteoarthropathy complicated with myelofibrosis and compound heterozygous SLCO2A1 mutations: a case report and review of literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Qirui","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Hematology, Fu Xing Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fu Xing Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fu Xing Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Peking University People\u2019s Hospital, National Clinical Research Center for Hematologic Diseases, Peking University Institute of Hematology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fu Xing Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.112.3.532","article-title":"Familial pachydermoperiostosis presenting as an acromegaly-like syndrome","volume":"112","author":"Harbison","year":"1971","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1235040","article-title":"Primary hypertrophic osteoarthropathy: Genetics, clinical features and management","volume":"14","author":"Lu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03722-3","article-title":"Distinct features of three clinical subtypes in 533 patients with primary hypertrophic osteoarthropathy","volume":"20","author":"Cai","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07405-z","article-title":"Primary hypertrophic osteoarthropathy with myelofibrosis and anemia: A case report and review of the literature","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal","year":"2008","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.11.019","article-title":"Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy","volume":"90","author":"Zhang","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0326","article-title":"Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosis","volume":"7","author":"Yuan","year":"2018","journal-title":"Endocr Connect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13023-019-1247-6","article-title":"Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: Two case reports and review of the literature","volume":"14","author":"Wang","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117258","article-title":"Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts","volume":"93","author":"Harada","year":"1994","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106339","article-title":"PGE2 in fibrosis and cancer: Insights into fibroblast activation","volume":"144","author":"Elwakeel","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22111","article-title":"Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis","volume":"33","author":"Diggle","year":"2012","journal-title":"Hum Mutat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30108","article-title":"Primary hypertrophic osteoarthropathy with myelofibrosis","volume":"14","author":"Yousaf","year":"2022","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1038\/s41598-017-09671-7","article-title":"Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:29Z","timestamp":1782793469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":14,"alternative-id":["10.3389\/fonc.2026.1772374"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1772374","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1772374"}}